Physician profile
Heather Alder
NPI 1578936530
$648.70
in general payments reported to CMS, 2019-2025
13 companies · $53.13 in 2025
The $53.13 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $71.32 · 2023: $483 · 2024: $41.35 · 2025: $53.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $148.70 | 2022-2023 | Aristada, Lybalvi |
| Lilly USA, LLC | $95.02 | 2023 | Mounjaro |
| Exact Sciences Corporation | $75.56 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.43 | 2023 | |
| Corium, LLC | $54.49 | 2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $45.16 | 2022-2023 | Airsupra, Breztri |
| Sanofi Pasteur INC. | $38.97 | 2022 | |
| Axsome Therapeutics, INC. | $31.08 | 2023 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $24.27 | 2023 | Abilify Asimtufii |
| Organon LLC | $20.28 | 2025 | Nexplanon |
| Neurocrine Biosciences, INC. | $20.23 | 2023 | Ingrezza |
| Hologic Sales and Service, LLC | $19.08 | 2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Glaxosmithkline, LLC. | $17.43 | 2025 | Bexsero, Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Alder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.